Eric is a Partner in Clarivate’s Commercial group, leads the team’s services in Japan and Asia Pacific. Eric brings 20 years of consulting experience, having worked at ZS Associates, Deloitte Tohmatsu Consulting, and L.E.K. Consulting.
His areas of focus include organic and inorganic growth strategy, market and therapy area entry strategy, market access strategy, portfolio prioritization and optimization, valuation and commercial due diligence, innovation and new business models and healthcare systems and policy.
Eric advises biopharmaceutical manufacturers based in Japan and Asia-Pacific on global expansion strategy, manufacturers elsewhere in the world on in-bound investment strategy into the Japan and Asia-Pacific region, as well as local affiliates on enhancing commercial operations.
Eric frequently publishes articles and thought pieces on latest trends in the Japanese healthcare environment. He publishes a monthly column in Pharma Japan and frequently speaks at industry conferences and events.
Eric is currently based in Tokyo, Japan and has been working in Japan and the Asia-Pacific region for the past 15 years.